Incannex Healthcare Inc. (IXHL) - Dilution Analysis

10-Q filing | 12.3M shares outstanding

8-K filing: Incannex Healthcare Inc. entered into a Securities Purchase Agreement to issue and sell 1,997,285 shares of common stock, pre-funded warrants to purchase up to 2,715 shares of common stock, and common stock warrants to purchase up to 2,000,000 shares of common stock in a registered direct offering. ($10.0M proceeds)

10-Q filing | 346.2M shares outstanding

10-K filing | 347.7M shares outstanding

8-K filing: Incannex Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution.

10-Q filing | 29.4M shares outstanding

S-1/A filing: This prospectus relates to the offer and sale by the selling stockholders of up to an aggregate of 75,902,171 shares of common stock of Incannex Healthcare Inc.

S-3 filing: Incannex Healthcare Inc. is offering 65,971,805 shares of common stock for resale by selling stockholders.

8-K filing: Incannex Healthcare Inc. closed a private placement on March 10, 2025, selling 9,687,045 shares of common stock at $1.08 per share, along with pre-funded warrants and Series A common stock warrants, raising approximately $11.3 million in net proceeds to fund clinical trials, research and development, and repay convertible debentures. ($12.5M proceeds)

10-Q filing | 17.6M shares outstanding

S-1/A filing: This prospectus relates to the offer and sale by the selling stockholders of up to 61,389,758 shares of common stock of Incannex Healthcare Inc.

10-Q filing | 17.6M shares outstanding

S-3 filing: This is an S-3 filing for a shelf offering of common stock by selling stockholders, an equity line of up to $50.0 million, and $3.0 million from a First Tranche Debenture.

S-3 filing: The company is filing an S-3 to offer and sell up to $150 million in the aggregate of common stock, preferred stock, and debt securities.

10-K filing | 16.2M shares outstanding

RW filing: Incannex Healthcare Inc. is seeking withdrawal of the Registration Statement because it is no longer pursuing a public offering of its shares of common stock, pre-funded warrants and common warrants at this time.

8-K filing: Incannex Healthcare Inc. entered into an equity line of credit agreement with Arena Business Solutions Global SPC II, Ltd for up to $50 million of the Company's shares of common stock and a Securities Purchase Agreement with Arena Investors, LP for up to $10 million in secured Convertible Notes.

S-1/A filing: The company is filing an S-1/A to offer 4,000,000 shares of common stock together with common warrants to purchase up to 4,000,000 shares of common stock and pre-funded warrants.

S-1 filing: The filing is for an offering of common stock together with common warrants, and pre-funded warrants to purchase common stock.

10-Q filing | 15.9M shares outstanding

10-Q filing | 15.9M shares outstanding

POS AM filing: This is a post-effective amendment to terminate the effectiveness of a registration statement due to the completion of a redomiciliation.

20-F filing | 1587.0M shares outstanding

F-3 filing: The filing is an F-3 type, indicating a shelf offering of American Depositary Shares (ADSs) representing Ordinary Shares and warrants. The specific terms, amounts, and prices will be detailed in future prospectus supplements.

20-F filing | 1292.3M shares outstanding

F-1 filing: This is an F-1 filing for American depositary shares and underwriter warrants.